WebmedCentral Editor
View all WebmedCentral Editors
 
No Image

Dr. Luiz Rizzo

Executive Director
Albert Einstein Jewsih Institute for Education & Research
Av. Morumbi 627, CEP 05652-000
 

Brief Biography:


Married to Christiana Correa-Sales, three children, graduated in Medicine from theUniversityofBrasiliain 1987, trained in pediatrics at theBrasilia GeneralHospitaluntil 1989. Fellow in Pediatric Immunology at the Stanford Medical Center from 1989 to 1992, Visiting Scientist at NIH from 1992 to 1995, Acting Section Chief at the Clinical Immunology Section of the National Eye Institute, NIH from 1995 to 1998, Assistant Professor of Immunology at the University of São Paulo from 1999 to 2001, Associate Professor of Immunology at the University of São Paulo from 2001-2002, Visiting Professor at the Center for Neurological Diseases, Brigham and Women´s Hospital, Harvard Medical School in 2002, Associate Professor at the MD Anderson Cancer Center from 2002 to 2003, Full Professor of immunology University of São Paulo 2005 to 2008. President of the Brazilian Society for Immunology 2006-2007. Executive Director, Instituto Israelita de Ensino e Pesquisa Albert Einstein since 2008. One hundred and eighteen papers published in peer reviewed journal and posted at Medline, thirty other non-medline. More than three thousand citations.

 

Academic positions:


 Assistant Professor of Immunology at the University of São Paulo from 1999 to 2001, Associate Professor of Immunology at the University of São Paulo from 2001-2002, Visiting Professor at the Center for Neurological Diseases, Brigham and Women´s Hospital, Harvard Medical School in 2002, Associate Professor at the MD Anderson Cancer Center from 2002 to 2003, Full Professor of immunology University of São Paulo 2005 to 2008. President

 

Research interests:


Immunodeficiency: molecular aspects of immunodeficiency in humans, with special regards to antibody deficiencies

Autoimmunity: immnoregulatory aspects autoimmunity in both humans and disease models. Special emphasis in cellular mechanisms of tolerance and molecular mechanisms or tolerance breakdown. Diseases in immunoprivilege sites, such as the eye and the central nervous system are of particular interest.

Immunotherapy; studies in animals models with emphasis on re-establishing tolerance.

 

What I think of the idea behind WebmedCentral:


Provide quality open information for all those that work in the Medical/Biomedical field, from research to clinical practive.